Eiger BioPharmaceuticals, Inc. (EIGR) Share-based Payment Arrangement, Expense USD 2013 - 2023

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Eiger BioPharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
Eiger BioPharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $683 K, a 62.9% decline year-over-year.
Eiger BioPharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $5.01 M, a 39.8% decline year-over-year.
Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.01 M, a 39.8% decline from 2022.
Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.32 M, a 5.27% increase from 2021.
Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.9 M, a 32.3% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2023	$5.01 M	$683 K	-$1.16 M	-62.9%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-08
Q3 2023	$6.17 M	$1.04 M	-$1.18 M	-53.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$7.35 M	$745 K	-$1.46 M	-66.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$8.81 M	$2.54 M	+$495 K	+24.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$8.32 M	$1.84 M	-$124 K	-6.31%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-08
Q3 2022	$8.44 M	$2.22 M	-$108 K	-4.64%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$8.55 M	$2.21 M	+$150 K	+7.29%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$8.4 M	$2.05 M	+$498 K	+32.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$7.9 M	$1.96 M	+$527 K	+36.7%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-17
Q3 2021	$7.37 M	$2.33 M	+$885 K	+61.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$6.49 M	$2.06 M	+$596 K	+40.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$5.89 M	$1.55 M	-$80 K	-4.91%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$5.97 M	$1.44 M	+$89 K	+6.6%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-17
Q3 2020	$5.88 M	$1.45 M	-$204 K	-12.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$6.09 M	$1.46 M	-$25 K	-1.68%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$6.11 M	$1.63 M	+$434 K	+36.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$5.68 M	$1.35 M	-$163 K	-10.8%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-10
Q3 2019	$5.84 M	$1.65 M	+$477 K	+40.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$5.37 M	$1.49 M	+$166 K	+12.6%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$5.2 M	$1.2 M	+$192 K	+19.1%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$5.01 M	$1.51 M	+$491 K	+48.1%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-09
Q3 2018	$4.52 M	$1.17 M	+$219 K	+23%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	$4.3 M	$1.32 M	+$375 K	+39.6%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	$3.92 M	$1 M	-$321 K	-24.2%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$4.24 M	$1.02 M	-$418 K	-29.1%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-13
Q3 2017	$4.66 M	$953 K	-$287 K	-23.1%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-09
Q2 2017	$4.95 M	$946 K	+$772 K	+444%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-10
Q1 2017	$4.18 M	$1.32 M	+$986 K	+292%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-11
Q4 2016	$3.19 M	$1.44 M	+$1.28 M	+828%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-14
Q3 2016	$1.91 M	$1.24 M	+$1.22 M	+5536%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-09
Q2 2016	$689 K	$174 K	+$127 K	+270%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-11
Q1 2016	$562 K	$338 K	+$335 K	+11167%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-12
Q4 2015	$227 K	$155 K	+$2.31 M		Oct 1, 2015	Dec 31, 2015	10-K	2018-03-09
Q3 2015	-$2.08 M	$22 K	-$889 K	-97.6%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-08
Q2 2015	-$1.19 M	$47 K	-$701 K	-93.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-10
Q1 2015	-$489 K	$3 K	-$516 K	-99.4%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-16
Q4 2014	$27 K	-$2.15 M	-$1.13 M	-111%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-23
Q3 2014	$1.16 M	$911 K	+$99 K	+12.2%	Jul 1, 2014	Sep 30, 2014	10-Q	2014-11-12
Q2 2014	$1.06 M	$748 K	+$561 K	+300%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-11
Q1 2014	$501 K	$519 K	+$440 K	+557%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-15
Q4 2013	$60.7 K	-$1.02 M			Oct 1, 2013	Dec 31, 2013	8-K/A	2016-06-17
Q3 2013		$812 K			Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-12
Q2 2013		$187 K			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-07
Q1 2013		$79 K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.